Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.

Lai X, Stiff A, Duggan M, Wesolowski R, Carson WE 3rd, Friedman A.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5534-5539. doi: 10.1073/pnas.1721559115. Epub 2018 May 7.

PMID:
29735668
2.

Updated report on incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant.

Chau E, Lundberg J, Phillips G, Berger M, Wesolowski R.

J Oncol Pharm Pract. 2018 Jan 1:1078155218769347. doi: 10.1177/1078155218769347. [Epub ahead of print]

PMID:
29651918
3.

Letter to the editor on the article "Alteration of redox status by commonly used antimalarial drugs in the north-western region of Nigeria" by Muhammad A et al.

Szewczyk-Golec K, Wesołowski R, Hołyńska-Iwan I.

Hum Exp Toxicol. 2018 Jan 1:960327118765327. doi: 10.1177/0960327118765327. [Epub ahead of print]

PMID:
29560742
4.

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.

Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace TA, Benner B, Kendra K, Campbell A, Gautam S, Abood D, Landi I, Hsu V, Duggan M, Wesolowski R, Old M, Howard JH, Yu L, Stasik N, Olencki T, Muthusamy N, Tridandapani S, Byrd JC, Caligiuri M, Carson WE.

Clin Cancer Res. 2018 Apr 15;24(8):1891-1904. doi: 10.1158/1078-0432.CCR-17-0691. Epub 2018 Jan 23.

PMID:
29363526
5.

Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease.

Eddowes PJ, McDonald N, Davies N, Semple SIK, Kendall TJ, Hodson J, Newsome PN, Flintham RB, Wesolowski R, Blake L, Duarte RV, Kelly CJ, Herlihy AH, Kelly MD, Olliff SP, Hübscher SG, Fallowfield JA, Hirschfield GM.

Aliment Pharmacol Ther. 2018 Mar;47(5):631-644. doi: 10.1111/apt.14469. Epub 2017 Dec 22.

PMID:
29271504
6.

Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet.

Szewczyk-Golec K, Rajewski P, Gackowski M, Mila-Kierzenkowska C, Wesołowski R, Sutkowy P, Pawłowska M, Woźniak A.

Oxid Med Cell Longev. 2017;2017:8494107. doi: 10.1155/2017/8494107. Epub 2017 Sep 21.

7.

Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.

Lustberg MB, Orchard TS, Reinbolt R, Andridge R, Pan X, Belury M, Cole R, Logan A, Layman R, Ramaswamy B, Wesolowski R, Berger M, Patterson E, Loprinzi C, Shapiro CL, Yee L.

Breast Cancer Res Treat. 2018 Feb;167(3):709-718. doi: 10.1007/s10549-017-4559-z. Epub 2017 Nov 3.

PMID:
29101597
8.

Comparative Efficacy of Topical Pertmehrin, Crotamiton and Sulfur Ointment in Treatment of Scabies.

Mila-Kierzenkowska C, Woźniak A, Krzyżyńska-Malinowska E, Kałużna L, Wesołowski R, Poćwiardowski W, Owcarz M.

J Arthropod Borne Dis. 2017 Mar 14;11(1):1-9. eCollection 2017 Mar.

9.

Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.

Wesolowski R, Duggan MC, Stiff A, Markowitz J, Trikha P, Levine KM, Schoenfield L, Abdel-Rasoul M, Layman R, Ramaswamy B, Macrae ER, Lustberg MB, Reinbolt RE, Mrozek E, Byrd JC, Caligiuri MA, Mace TA, Carson WE 3rd.

Cancer Immunol Immunother. 2017 Nov;66(11):1437-1447. doi: 10.1007/s00262-017-2038-3. Epub 2017 Jul 7.

PMID:
28688082
10.

Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.

McMichael EL, Courtney NB, Duggan MC, Wesolowski R, Quiroga D, Kondadasula SV, Atwal LS, Bhave N, Luedke E, Jaime-Ramirez AC, Campbell AR, Mo X, Byrd JC, Carson Iii WE.

Oncoimmunology. 2017 May 2;6(5):e1312045. doi: 10.1080/2162402X.2017.1312045. eCollection 2017.

11.

Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB.

Breast Cancer Res Treat. 2017 Jul;164(1):69-77. doi: 10.1007/s10549-017-4230-8. Epub 2017 Apr 3.

PMID:
28374323
12.

Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator.

Trikha P, Plews RL, Stiff A, Gautam S, Hsu V, Abood D, Wesolowski R, Landi I, Mo X, Phay J, Chen CS, Byrd J, Caligiuri M, Tridandapani S, Carson W.

Oncoimmunology. 2016 Jul 25;5(9):e1214787. eCollection 2016.

13.

Water nanodroplet on a graphene surface-a new old system.

Włoch J, Terzyk AP, Gauden PA, Wesołowski R, Kowalczyk P.

J Phys Condens Matter. 2016 Dec 14;28(49):495002. Epub 2016 Oct 13.

PMID:
27736807
14.

Impact of coronary bifurcation morphology on wave propagation.

Rivolo S, Hadjilucas L, Sinclair M, van Horssen P, van den Wijngaard J, Wesolowski R, Chiribiri A, Siebes M, Smith NP, Lee J.

Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H855-H870. doi: 10.1152/ajpheart.00130.2016. Epub 2016 Jul 8.

15.

Dynamics of effusive and diffusive gas separation on pillared graphene.

Wesołowski RP, Terzyk AP.

Phys Chem Chem Phys. 2016 Jun 22;18(25):17018-23. doi: 10.1039/c6cp02392d.

PMID:
27297664
16.

Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.

Stiff A, Trikha P, Wesolowski R, Kendra K, Hsu V, Uppati S, McMichael E, Duggan M, Campbell A, Keller K, Landi I, Zhong Y, Dubovsky J, Howard JH, Yu L, Harrington B, Old M, Reiff S, Mace T, Tridandapani S, Muthusamy N, Caligiuri MA, Byrd JC, Carson WE 3rd.

Cancer Res. 2016 Apr 15;76(8):2125-36. doi: 10.1158/0008-5472.CAN-15-1490. Epub 2016 Feb 15.

17.

Blood Oxygenation Level-Dependent CMR-Derived Measures in Critical Limb Ischemia and Changes With Revascularization.

Bajwa A, Wesolowski R, Patel A, Saha P, Ludwinski F, Ikram M, Albayati M, Smith A, Nagel E, Modarai B.

J Am Coll Cardiol. 2016 Feb 2;67(4):420-431. doi: 10.1016/j.jacc.2015.10.085.

18.

Plasmodium knowlesi as a Threat to Global Public Health.

Wesolowski R, Wozniak A, Mila-Kierzenkowska C, Szewczyk-Golec K.

Korean J Parasitol. 2015 Oct;53(5):575-81. doi: 10.3347/kjp.2015.53.5.575. Epub 2015 Oct 29. Review.

19.

Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.

Mangini NS, Wesolowski R, Ramaswamy B, Lustberg MB, Berger MJ.

Ann Pharmacother. 2015 Nov;49(11):1252-60. doi: 10.1177/1060028015602273. Epub 2015 Aug 31. Review.

PMID:
26324355
20.

Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin.

Pahouja G, Wesolowski R, Reinbolt R, Tozbikian G, Berger M, Mangini N, Lustberg MB.

Cancer Treat Commun. 2015;3:28-32.

21.

Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure.

Sammut E, Zarinabad N, Wesolowski R, Morton G, Chen Z, Sohal M, Carr-White G, Razavi R, Chiribiri A.

J Cardiovasc Magn Reson. 2015 Feb 12;17:13. doi: 10.1186/s12968-015-0124-2.

22.

Activity of α1-antitrypsin and some lysosomal enzymes in the blood serum of patients with chronic obstructive pulmonary disease after smoking cessation.

Woźniak B, Woźniak A, Konca J, Górecki D, Mila-Kierzenkowska C, Szpinda M, Sutkowy P, Wesołowski R.

Biomed Res Int. 2015;2015:176582. doi: 10.1155/2015/176582. Epub 2015 Jan 31.

23.
24.

Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials.

Hicks M, Macrae ER, Abdel-Rasoul M, Layman R, Friedman S, Querry J, Lustberg M, Ramaswamy B, Mrozek E, Shapiro C, Wesolowski R.

Oncologist. 2015 Apr;20(4):337-43. doi: 10.1634/theoncologist.2014-0334. Epub 2015 Mar 2.

25.

Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer.

Oostra DR, Lustberg MB, Reinbolt RE, Pan X, Wesolowski R, Shapiro CL.

Mol Cell Endocrinol. 2015 Feb 15;402:51-6. doi: 10.1016/j.mce.2014.12.028. Epub 2015 Jan 6.

26.

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.

Berger MJ, Vargo C, Vincent M, Shaver K, Phillips G, Layman R, Macrae E, Mrozek E, Ramaswamy B, Wesolowski R, Shapiro CL, Lustberg MB.

Support Care Cancer. 2015 Jul;23(7):2019-24. doi: 10.1007/s00520-014-2556-x. Epub 2014 Dec 18.

27.

A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer.

Campa VM, Baltziskueta E, Bengoa-Vergniory N, Gorroño-Etxebarria I, Wesołowski R, Waxman J, Kypta RM.

Oncotarget. 2014 Sep 30;5(18):8173-87.

28.

Assessment of tissue perfusion in the lower limb: current methods and techniques under development.

Bajwa A, Wesolowski R, Patel A, Saha P, Ludwinski F, Smith A, Nagel E, Modarai B.

Circ Cardiovasc Imaging. 2014 Sep;7(5):836-43. doi: 10.1161/CIRCIMAGING.114.002123. Review. No abstract available.

29.

Enhancing coronary Wave Intensity Analysis robustness by high order central finite differences.

Rivolo S, Asrress KN, Chiribiri A, Sammut E, Wesolowski R, Bloch LO, Grøndal AK, Hønge JL, Kim WY, Marber M, Redwood S, Nagel E, Smith NP, Lee J.

Artery Res. 2014 Sep;8(3):98-109.

30.

Oxidative stress in blood of healthy people after diving.

Mila-Kierzenkowska C, Woźniak A, Szpinda M, Wesołowski R, Sutkowy P, Włodarski A.

J Sports Med Phys Fitness. 2015 Apr;55(4):352-60. Epub 2014 Jul 29.

PMID:
25069962
31.

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Zhao M, Pan X, Layman R, Lustberg MB, Mrozek E, Macrae ER, Wesolowski R, Carothers S, Puhalla S, Shapiro CL, Ramaswamy B.

Invest New Drugs. 2014 Dec;32(6):1285-94. doi: 10.1007/s10637-014-0122-5. Epub 2014 Jun 5.

32.

Treatment-related mortality with everolimus in cancer patients.

Wesolowski R, Abdel-Rasoul M, Lustberg M, Paskell M, Shapiro CL, Macrae ER.

Oncologist. 2014 Jun;19(6):661-8. doi: 10.1634/theoncologist.2013-0355. Epub 2014 May 2.

33.

Primary prevention of cancer-related thrombosis: special focus on ambulatory patients.

Arcopinto M, Cella CA, Wesolowski R, Salzano A, Bossone E, Cittadini A, Baliga RR.

Int J Cardiol. 2014 May 15;173(3):583-4. doi: 10.1016/j.ijcard.2014.03.109. Epub 2014 Mar 20. No abstract available.

PMID:
24698248
34.

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ.

Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.

35.

Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant.

Lundberg JD, Crawford BS, Phillips G, Berger MJ, Wesolowski R.

Support Care Cancer. 2014 Jun;22(6):1461-6. doi: 10.1007/s00520-013-2106-y. Epub 2014 Jan 9.

36.

Myeloid-derived suppressor cells in breast cancer.

Markowitz J, Wesolowski R, Papenfuss T, Brooks TR, Carson WE 3rd.

Breast Cancer Res Treat. 2013 Jul;140(1):13-21. doi: 10.1007/s10549-013-2618-7. Epub 2013 Jul 5. Review.

37.

Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.

Wenzell CM, Berger MJ, Blazer MA, Crawford BS, Griffith NL, Wesolowski R, Lustberg MB, Phillips GS, Ramaswamy B, Mrozek E, Flynn JM, Shapiro CL, Layman RM.

Support Care Cancer. 2013 Oct;21(10):2845-51. doi: 10.1007/s00520-013-1865-9. Epub 2013 Jun 8.

38.

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Poi MJ, Berger M, Lustberg M, Layman R, Shapiro CL, Ramaswamy B, Mrozek E, Olson E, Wesolowski R.

Support Care Cancer. 2013 Oct;21(10):2679-86. doi: 10.1007/s00520-013-1842-3. Epub 2013 May 19.

39.

Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.

Layman RM, Ruppert AS, Lynn M, Mrozek E, Ramaswamy B, Lustberg MB, Wesolowski R, Ottman S, Carothers S, Bingman A, Reinbolt R, Kraut EH, Shapiro CL.

Cancer Chemother Pharmacol. 2013 May;71(5):1183-90. doi: 10.1007/s00280-013-2112-2. Epub 2013 Feb 21.

40.

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer.

Wesolowski R, Markowitz J, Carson WE 3rd.

J Immunother Cancer. 2013 Jul 15;1:10. doi: 10.1186/2051-1426-1-10. eCollection 2013. Review.

41.

Transcriptional repression of Hox genes by C. elegans HP1/HPL and H1/HIS-24.

Studencka M, Wesołowski R, Opitz L, Salinas-Riester G, Wisniewski JR, Jedrusik-Bode M.

PLoS Genet. 2012 Sep;8(9):e1002940. doi: 10.1371/journal.pgen.1002940. Epub 2012 Sep 13.

42.
43.

Pillared graphene as a gas separation membrane.

Wesołowski RP, Terzyk AP.

Phys Chem Chem Phys. 2011 Oct 14;13(38):17027-9. doi: 10.1039/c1cp21590f. Epub 2011 Sep 6.

PMID:
21897957
44.

Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?

Costa R, Wesolowski R, Raghavan D.

BJU Int. 2011 Nov;108(10):1546-54. doi: 10.1111/j.1464-410X.2011.10464.x. Epub 2011 Aug 24. Review.

45.

Phenol adsorption on closed carbon nanotubes.

Pacholczyk A, Terzyk AP, Wiśniewski M, Gauden PA, Wesołowski RP, Furmaniak S, Szcześ A, Chibowski E, Kruszka B.

J Colloid Interface Sci. 2011 Sep 1;361(1):288-92. doi: 10.1016/j.jcis.2011.05.032. Epub 2011 May 19.

PMID:
21652046
46.

Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.

Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GT, Stark GR, Eng C.

Breast Cancer Res Treat. 2012 Feb;131(3):849-58. doi: 10.1007/s10549-011-1500-8. Epub 2011 Apr 9.

47.

Molecular dynamics of zigzag single walled carbon nanotube immersion in water.

Gauden PA, Terzyk AP, Pieńkowski R, Furmaniak S, Wesołowski RP, Kowalczyk P.

Phys Chem Chem Phys. 2011 Apr 7;13(13):5621-9. doi: 10.1039/c0cp02028a. Epub 2011 Feb 7.

PMID:
21301707
48.

A young woman with a breast mass: What every internist should know.

Wesolowski R, Budd GT.

Cleve Clin J Med. 2010 Aug;77(8):537-46. doi: 10.3949/ccjm.77a.09095. No abstract available.

PMID:
20682516
49.

Activated carbon immersed in water-the origin of linear correlation between enthalpy of immersion and oxygen content studied by molecular dynamics simulation.

Terzyk AP, Gauden PA, Furmaniak S, Wesołowski RP, Kowalczyk P.

Phys Chem Chem Phys. 2010 Sep 28;12(36):10701-13. doi: 10.1039/c003894f. Epub 2010 Jul 29.

PMID:
20668768
50.

Hepatocellular carcinoma metastatic to uvea.

Wesolowski R, Chung JY, Singh A, Kim R.

Retin Cases Brief Rep. 2010 Spring;4(2):178-80. doi: 10.1097/ICB.0b013e31819f1fd3.

PMID:
25390396

Supplemental Content

Loading ...
Support Center